Internal Medicine, Nephrology · Humacao, PR
NPI
1578827309
Since 2012
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
111 Calle Cruz Ortiz Stella S
Humacao, PR, 00791
Phone (787) 719-4051
Medicare paid, 2024
$5,709
76 services
Medicare patients, 2024
27
Average age 77
Drug cost, 2024
$3.1M
11,686 prescriptions
Company payments, 2025
$125
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Fatima B Cintron-Rosa was code 99214 (office e&m - established), 27 times for 13 patients. In total Fatima B Cintron-Rosa billed 76 services in 6 codes, and Medicare paid $5,709.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 27 | 13 | $93.39 | $2,521 |
By year: 2022 $9,705 for 120 services; 2023 $4,519 for 58 services; 2024 $5,709 for 76 services.
Medicare prescription drug claims, 2024
In 2024, the drug Fatima B Cintron-Rosa prescribed most often to Medicare patients was Farxiga (Dapagliflozin Propanediol), with 991 prescriptions and refills. In total Fatima B Cintron-Rosa wrote 11,686 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Farxiga Dapagliflozin Propanediol | 991 | 1,464 | 224 | $854K |
| Losartan Potassium Generic | 690 | 1,681 | 234 | $9,762 |
| Jardiance Empagliflozin | 623 | 778 | 140 | $480K |
| Allopurinol Generic | 593 | 1,414 | 180 | $6,490 |
| Kerendia Finerenone | 578 | 690 | 100 | $457K |
| Amlodipine Besylate Generic | 536 | 1,212 | 173 | $2,658 |
| Doxazosin Mesylate Generic | 472 | 1,063 | 142 | $12K |
| Atorvastatin Calcium Generic | 465 | 1,152 | 159 | $5,315 |
| Irbesartan Generic | 417 | 1,054 | 129 | $14K |
| Lisinopril Generic | 348 | 896 | 127 | $2,195 |
| Chlorthalidone Generic | 279 | 604 | 88 | $4,504 |
| Famotidine Generic | 255 | 575 | 92 | $2,360 |
| Spironolactone Generic | 221 | 479 | 60 | $2,362 |
| Candesartan Cilexetil Generic | 213 | 461 | 65 | $22K |
| Furosemide Generic | 212 | 478 | 73 | $1,199 |
Brand drugs: 3,565 claims; generic drugs: 8,029 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Fatima B Cintron-Rosa $125 ($125 in general payments such as food, travel and fees) from 2 companies. The largest payer was Vifor Pharma, Inc. with $90.17.
| Company | Payments | Amount |
|---|---|---|
| Vifor Pharma, Inc. | 4 | $90.17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $34.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.